Wellbeing Nutrition Acquired

Brand emphasizes lab-tested, non-GMO, sugar-free formulations with "No Sugar, Preservatives or Fillers" and a "Traceable Ingredients" claim.

Proprietary "Advanced Nano" technology used to formulate nutraceuticals consumed as oral strips ("Melts") or effervescent tablets.

Company's own site lists a "Slow Time Release 2-in-1 Capsules" product line and multiple Liposomal-delivery SKUs (e.g. Liposomal Glutathione, Liposomal Magnesium Glycinate, Liposomal Zinc Complex, Liposomal Iron Complex).

Founded to provide organic, non-genetically-modified vitamins and minerals as a domestically accessible alternative to costlier imported products.

Founder positioned the brand as an accessible alternative because "few people could afford imported health supplements."

Homepage customer testimonials are attributed to a Nutritionist, a Yoga Expert (self-described as vegan and plant-based), a Dance Instructor, and a Socialite & Digital Creator — pointing to health/wellness-adjacent professionals and lifestyle-content audiences as a core segment, rather than the broader "fitness enthusiasts, vegans, busy professionals, parents, and seniors" demographic list previously (and inaccurately) attributed to the site as a direct quote.

Bollywood actor Rakul Preet Singh and personality Mira Kapoor are cap-table investors who back the D2C brand, lending it consumer-facing visibility.

Primary D2C channel is the brand's own e-commerce website plus an iOS/Android app.

Distribution through retail chains including Apollo Pharmacy and WH Smith, with presence across over 3,000 stores in India by end of 2022.

Ongoing development of new formats/technologies (nano-tech, liposomal, time-release capsules, oral strips) to expand its SKU range across immunity, beauty and sports-nutrition categories.

Managing growth across its own D2C site/app and an expanding offline retail footprint (3,000+ stores).

Cap table and marketing built around celebrity investor-backers such as Rakul Preet Singh and Mira Kapoor.

"Advanced Nano" technology used in its oral strip and effervescent tablet formulations.

Liposomal-delivery formulations (e.g., Liposomal Glutathione, Liposomal Magnesium Glycinate, Liposomal Zinc Complex, Liposomal Iron Complex) across its nutraceutical range.

R&D team includes gastroenterologists and nutritionists drawn from multiple countries.

Manufacturing is approved by the U.S. FDA and FSSAI-certified.

Ingredients sourced from "200 organic farms and certified companies in 19 countries."

Lead Series A/Series B investor; venture partner Kannan Sitaram joined the company's board.

Strategic investor holding a 19.8% stake (2022–2026) that co-led the Series B round and joined the company's board before exiting via the USV deal.

Pharma/nutraceutical solutions provider that participated in the Series A round and led the 2025 debt (OCD) round.

Co-branded plant-based "melts" product line for kids launched in 2022.

Acquired a 79% stake in February 2026 and now serves as strategic/majority parent.

Primary revenue stream is direct sales via the company's own website and app.

Sales through pharmacy chains and general retail (Apollo Pharmacy, WH Smith) across 3,000+ stores.

Launched Disney-branded plant-based "melts" aimed at kids in 2022 as a licensed co-branded product line.

Total expenses were ₹104 Cr in FY24 against ₹71.96 Cr revenue, reflecting the cost of scaling the business ahead of profitability.

Costs tied to maintaining a multi-country R&D team (gastroenterologists, nutritionists) and US FDA-approved, FSSAI-certified manufacturing.